• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.11% Nasdaq Down 0.26%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    141.58 Up 0.17(0.12%) 1:33PM EDT - Nasdaq Real Time Price
    Prev Close:141.41
    Open:142.16
    Bid:141.50 x 300
    Ask:141.67 x 100
    1y Target Est:195.74
    Beta:1.42705
    Earnings Date:Jul 28 - Aug 1 (Est.)
    Day's Range:140.36 - 143.72
    52wk Range:124.16 - 208.88
    Volume:511,104
    Avg Vol (3m):1,674,740
    Market Cap:31.81B
    P/E (ttm):211.31
    EPS (ttm):0.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNUp 0.12%31.81B
    AMGNDown 0.30%115.44B
    BAXUp 0.11%24.85B

    Key Statistics

    Forward P/E (1 yr):21.51
    P/S (ttm):12.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :5.06
    Quarterly EPS Est (Jun-16) :1.18
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.41

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback